Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-06-30
1991-06-25
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 31555
Patent
active
050266942
ABSTRACT:
Methods to inhibit tumor growth and to radiosensitize hypoxic cells and pharmaceutical compositions therefor are disclosed. These methods and compositions use compounds of the formula
REFERENCES:
patent: 3794648 (1974-02-01), Hammond et al.
patent: 3879416 (1975-04-01), Kraus et al.
patent: 4511715 (1985-04-01), Palensky et al.
patent: 4661516 (1987-04-01), Brown et al.
Rosenberg (1980) "Cisplatin: Its History and Possible Mechanisms of Action," (Academic Press) pp. 9-20.
Roberts (1981) "The Mechanism of Action of Anti-Tumour Platinum Coordination Compounds," (Elsevier) pp. 273-332.
Rosenberg (1978), interdisciplinary Science Reviews, 3(2):4-29.
Doadrio, et al. (1978), Inorganic Perspectives in Biology and Medicine, 1:223-231.
Farrell, et al. (1982), Radiation Research, 91:378 (abstract).
Skov, et al., Abstracts of Papers for the Thirty-Second Annual Meeting of the Radiation Research Society, Orlando, Florida, Mar. 25-29, 1984.
Chan, et al., Abstracts of the Papers for the Thirty-Third Annual Meeting of the Radiation Research Society, Los Angeles, CA, May 5-9, 1985.
Skov, et al., Abstracts of Papers for the Thirty-Third Annual Meeting of the Radiation Research Society, Los Angeles, CA, May 5-9, 1985.
Adomat, et al., Abstracts of Papers for the Thirty-Fourth Annual Meeting of the Radiation Research Society, Las Vegas, Nevada, Apr. 12-17, 1986.
Chan, et al., (1986), Int. J. Radiation Oncology Biol. Phys., 12:1059-1062.
Chan, et al., (1986) Chem. Biol. Interaction, 59:247-254.
Farrell, et al., (1984) Inorganica Chemica Acts, 92:61-66.
Bales, et al., (1982), Br. J. Cancer, 46:701-705.
Chibber, et al., (1984), Radiation Oncology Biol. Phys., 10:1213-1215.
Bocian, et al., (1983), Br. J. Cancer, 48:803-807.
Teicher, et al., (1985), Int. J. Radiation Oncology Biol. Phys., 11:937-941.
Skov, et al., (1987) Chem. Biol. Interact., 62:117-129.
Chaplin David J.
Farrell Nicholas P.
Skov Kirsten A.
Friedman Stanley J.
Hollinden Gary E.
The British Columbia Cancer Foundation
LandOfFree
Platinum complexes with one radiosensitizing ligand does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platinum complexes with one radiosensitizing ligand, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platinum complexes with one radiosensitizing ligand will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1039964